HK1004949A1 - Immunoreactive and immunotherapeutic molecules which interact in subjects with insulin-dependent diabetes mellitus (iddm) - Google Patents
Immunoreactive and immunotherapeutic molecules which interact in subjects with insulin-dependent diabetes mellitus (iddm)Info
- Publication number
- HK1004949A1 HK1004949A1 HK98103242A HK98103242A HK1004949A1 HK 1004949 A1 HK1004949 A1 HK 1004949A1 HK 98103242 A HK98103242 A HK 98103242A HK 98103242 A HK98103242 A HK 98103242A HK 1004949 A1 HK1004949 A1 HK 1004949A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- iddm
- subjects
- insulin
- immunoreactive
- diabetes mellitus
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/81—Drug, bio-affecting and body treating compositions involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, immunotolerance, or anergy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Endocrinology (AREA)
- Biotechnology (AREA)
- Rehabilitation Therapy (AREA)
- Pathology (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- General Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPN1239A AUPN123995A0 (en) | 1995-02-20 | 1995-02-20 | Immunointeractive molecules |
AUPN5172A AUPN517295A0 (en) | 1995-09-04 | 1995-09-04 | Immunointeractive and immunotherapeutic molecules |
PCT/AU1996/000085 WO1996026218A1 (en) | 1995-02-20 | 1996-02-20 | Immunoreactive and immunotherapeutic molecules which interact in subjects with insulin-dependent diabetes mellitus (iddm) |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1004949A1 true HK1004949A1 (en) | 1998-12-18 |
Family
ID=25644867
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK98103242A HK1004949A1 (en) | 1995-02-20 | 1998-04-17 | Immunoreactive and immunotherapeutic molecules which interact in subjects with insulin-dependent diabetes mellitus (iddm) |
Country Status (9)
Country | Link |
---|---|
US (2) | US6818217B1 (de) |
EP (2) | EP1849870A1 (de) |
JP (1) | JP3778936B2 (de) |
AT (1) | ATE364701T1 (de) |
CA (1) | CA2213301C (de) |
DE (1) | DE69637130T2 (de) |
ES (1) | ES2289751T3 (de) |
HK (1) | HK1004949A1 (de) |
WO (1) | WO1996026218A1 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19525784A1 (de) * | 1995-07-14 | 1997-01-16 | Boehringer Mannheim Gmbh | Autoreaktive Peptide aus der humanen Glutamin-Decarboxylase (GAD) |
US7361331B2 (en) | 1996-10-18 | 2008-04-22 | Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture And Agri-Food | Plant bioreactors |
US6777546B2 (en) | 1997-10-07 | 2004-08-17 | Loma Linda University | Methods and substances for preventing and treating autoimmune disease |
US7422747B2 (en) | 1997-10-07 | 2008-09-09 | Loma Linda University | Transgenic plant-based vaccines |
SE9704451D0 (sv) * | 1997-11-28 | 1997-11-28 | Diamyd Therapeutics Ab | New method and compositions for the treatment of autoimmune diseases |
US6982323B1 (en) | 1997-12-23 | 2006-01-03 | Alexion Pharmaceuticals, Inc. | Chimeric proteins for diagnosis and treatment of diabetes |
AU2205099A (en) * | 1997-12-23 | 1999-07-12 | Alexion Pharmaceuticals, Inc. | Chimeric proteins for the treatment of diabetes |
WO1999054452A1 (en) * | 1998-04-22 | 1999-10-28 | Loma Linda University | Methods and substances for preventing and treating autoimmune disease |
CA2387652A1 (en) * | 1999-10-22 | 2001-05-03 | The Walter And Eliza Hall Institute Of Medical Research | A method of prophylaxis and treatment |
GB0105360D0 (en) * | 2001-03-03 | 2001-04-18 | Glaxo Group Ltd | Chimaeric immunogens |
US20050004001A1 (en) * | 2002-10-02 | 2005-01-06 | Robert Harris | Formulation of antigen |
US20050250691A1 (en) * | 2004-05-10 | 2005-11-10 | Diamyd Therapeutics Ab | Immunomodulation by a therapeutic medication intended for treatment of diabetes and prevention of autoimmune diabetes |
US20050209138A1 (en) * | 2004-03-19 | 2005-09-22 | Diamyd Therapeutics Ab | Immunomodulation by a therapeutic medication intended for treatment of diabetes and prevention of autoimmune diabetes |
BRPI0810816A2 (pt) * | 2007-04-24 | 2014-10-21 | Diamyd Therapeutics Ab | Medicamento e métodos para tratar doenças auto-imune e câncer |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4569792A (en) * | 1984-06-14 | 1986-02-11 | Eli Lilly And Company | Anti-diabetic compounds |
US5674978A (en) * | 1990-09-21 | 1997-10-07 | The Regents Of The University Of California | Peptides derived from glutamic acid decarboxylase |
US6682906B1 (en) | 1990-09-21 | 2004-01-27 | The Regents Of The University Of California | Cloned glutamic acid decarboxylase |
ATE304050T1 (de) * | 1991-02-22 | 2005-09-15 | Inst Medical W & E Hall | Hbgad und higad polypeptide und nukleinsäuren und deren verwendung zur diagnose und behandlung von gad autoantigen assoziierten krankheiten |
IL101872A0 (en) * | 1991-05-15 | 1992-12-30 | Univ Washington | Cloning and expression of human islet glutamic acid decarboxylase autoantigen |
RU2036592C1 (ru) | 1991-08-16 | 1995-06-09 | Моисей Михайлович Лернер | Устройство для распределения предметов на технологические потоки |
CZ342492A3 (en) * | 1991-11-26 | 1993-06-16 | Lilly Co Eli | Derivatives of tri-arginine insulin, process of their preparation and a pharmaceutical composition in which said derivatives are comprised |
ES2097426T3 (es) * | 1992-12-02 | 1997-04-01 | Hoechst Ag | Procedimiento para la obtencion de proinsulina con puentes de cistina correctamente unidos. |
WO1994012529A1 (en) * | 1992-12-03 | 1994-06-09 | The Regents Of The University Of California | Improved reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome |
US5547847A (en) * | 1993-09-07 | 1996-08-20 | University Of Washington | Diagnosis of insulin-dependent diabetes |
US6509165B1 (en) * | 1994-07-08 | 2003-01-21 | Trustees Of Dartmouth College | Detection methods for type I diabetes |
CN1157621A (zh) | 1994-07-08 | 1997-08-20 | 达特茅斯大学理事会 | 用于检测和治疗i型糖尿病的胰岛素原肽化合物 |
-
1996
- 1996-02-20 WO PCT/AU1996/000085 patent/WO1996026218A1/en active IP Right Grant
- 1996-02-20 JP JP52523896A patent/JP3778936B2/ja not_active Expired - Fee Related
- 1996-02-20 US US08/663,272 patent/US6818217B1/en not_active Expired - Fee Related
- 1996-02-20 EP EP07006946A patent/EP1849870A1/de not_active Withdrawn
- 1996-02-20 EP EP96902180A patent/EP0815136B1/de not_active Expired - Lifetime
- 1996-02-20 CA CA2213301A patent/CA2213301C/en not_active Expired - Fee Related
- 1996-02-20 ES ES96902180T patent/ES2289751T3/es not_active Expired - Lifetime
- 1996-02-20 AT AT96902180T patent/ATE364701T1/de not_active IP Right Cessation
- 1996-02-20 DE DE69637130T patent/DE69637130T2/de not_active Expired - Fee Related
-
1998
- 1998-04-17 HK HK98103242A patent/HK1004949A1/xx not_active IP Right Cessation
-
2002
- 2002-01-07 US US10/040,815 patent/US7455984B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH11500719A (ja) | 1999-01-19 |
ATE364701T1 (de) | 2007-07-15 |
DE69637130T2 (de) | 2008-02-21 |
WO1996026218A1 (en) | 1996-08-29 |
DE69637130D1 (de) | 2007-07-26 |
EP0815136B1 (de) | 2007-06-13 |
ES2289751T3 (es) | 2008-02-01 |
US6818217B1 (en) | 2004-11-16 |
CA2213301A1 (en) | 1996-08-29 |
US20020142004A1 (en) | 2002-10-03 |
EP0815136A4 (de) | 2001-02-07 |
EP1849870A1 (de) | 2007-10-31 |
US7455984B2 (en) | 2008-11-25 |
EP0815136A1 (de) | 1998-01-07 |
JP3778936B2 (ja) | 2006-05-24 |
CA2213301C (en) | 2010-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1004949A1 (en) | Immunoreactive and immunotherapeutic molecules which interact in subjects with insulin-dependent diabetes mellitus (iddm) | |
NZ512083A (en) | Methods of increasing lean tissue mass using OB protein compositions | |
EP2311952A3 (de) | Antikörper gegen MART-1 Protein oder Fragmenten davon | |
CA2124953A1 (en) | Peptides related to prion proteins | |
AU4188789A (en) | Urethane-protected amino acid-n-carboxyanhydrides | |
DK228190A (da) | Rajgraespollenallergen | |
UA42040C2 (uk) | Поліпептид, спосіб діагностики інсулінозалежного цукрового діабету (iddm), що розвинувся або що розвивається (варіанти), набір для діагностики iddm (варіанти), препарат для запобігання або лікування iddm, фармацевтична композиція для профілактики або лікування iddm | |
AU626636B2 (en) | Pancreatic islet cell antigens obtained by molecular cloning | |
PT929669E (pt) | Antigenios derivados das filagrinas e a sua utilizacao para o diagostico da poliartrite reumatoide | |
CA2268029A1 (en) | Therapeutic and diagnostic applications of laminin and laminin-derived protein fragments | |
WO1996021734A3 (en) | P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods | |
ATE86633T1 (de) | Snrnp-a-antigen und fragmente davon. | |
EP0722499A4 (de) | Immunoreaktive antigene des hepatitis e viruses | |
AU638155B2 (en) | Peptides with a characteristic antigenic determinant for alphal-microglobulin | |
EP0885959A3 (de) | Menschlisches Wnt-5b Protein | |
GR3033242T3 (en) | Arylazo chromoionophores. | |
AU1541395A (en) | Folding proteins | |
CA2140091A1 (en) | Peptides and antisera for detecting human cyclooxygenase-1 and cyclooxygenase-2 | |
MX9800191A (es) | Peptidos novedosos derivados de proteina humana 60 producida por choque termico, para tratamiento de diabetes, composiciones, metodos y equipos. | |
NO304233B1 (no) | Polypeptid og sett for diagnostisering av insulinavhengig diabetes mellitus samt fremstilling av slikt materiale | |
AU4659796A (en) | Immunoreactive and immunotherapeutic molecules which interact in subjects with insulin-dependent diabetes mellitus (iddm) | |
FI961398A (fi) | Menetelmä terapeuttisesti käyttökelpoisen peptidin valmistamiseksi | |
GR890100333A (en) | Antihuman antigen antibodies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20110220 |